New Study Evaluates High Dose Ivermectin, Fluvoxamine, and Metformin for Outpatient COVID-19


MedCram – Medical Lectures Explained CLEARLY

Roger Seheult, MD of MedCram examines a new study comparing high dose Ivermectin, Fluvoxamine, and Metformin for outpatient COVID-19.

See all Dr. Seheult’s videos at:

Roger Seheult, MD is the co-founder and lead professor at He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 (NEJM) |…

Mission (Parsemus Foundation) |

Prevention Protocol (FLCCC) |…

DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

#COVID19 #Omicron #Coronavirus